In this study, we construct a prognosis risk model to predict the overall survival (OS) outcomes of NSCLC patients based on the expression of five hub ANKRD genes (ANKRD29, ANKRD34B, ANKRD40CL, ANKRD44 and ANKRD66). This evidence concerns the gene ANKRD40CL and non-small cell lung carcinoma.